Although the patient has been still receiving Aİ diffuse erythematous plaques with an erysipel-like appearence occured located over the left side of the anterior chest wall and extending far from the mastectomy incision through the infraclavicular area, axilla, and back including scapular region.We observed complete clinical response after this chemotheraphy regimen.Today the patient has been still under following up since diagnosed with erisypeloid carcinoma without any local recurrences for 24 months.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:We described in this case report a 62 year-old women with a history of modified radical mastectomy for an invasive ductal carcinoma of the left breast 3 years previously (StageIIIA-Cerb-b2‘ (+), ER(-), PR %75 (+)).
📊
Key Findings & Data:We described in this case report a 62 year-old women with a history of modified radical mastectomy for an invasive ductal carcinoma of the left breast 3 years previously (StageIIIA-Cerb-b2‘ (+), ER(-), PR %75 (+)).
💡
Conclusion & Impact:Although the patient has been still receiving Aİ diffuse erythematous plaques with an erysipel-like appearence occured located over the left side of the anterior chest wall and extending far from the mastectomy incision through the infraclavicular area, axilla, and back including scapular region.We observed complete clinical response after this chemotheraphy regimen.Today the patient has been still under following up since diagnosed with erisypeloid carcinoma without any local recurrences for 24 months.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Breast · Breast cancer · Metastases
Abstract
We described in this case report a 62 year-old women with a history of modified radical mastectomy for an invasive ductal carcinoma of the left breast 3 years previously (StageIIIA-Cerb-b2‘ (+), ER(-), PR %75 (+)). Although the patient has been still receiving Aİ diffuse erythematous plaques with an erysipel-like appearence occured located over the left side of the anterior chest wall and extending far from the mastectomy incision through the infraclavicular area, axilla, and back including scapular region.We observed complete clinical response after this chemotheraphy regimen.Today the patient has been still under following up since diagnosed with erisypeloid carcinoma without any local recurrences for 24 months.
Polat, A. K., Polat, A., Işık, S., Alpakut, S., Güngör, B. (2012). Carcinoma Erysipeloides: A Rare Form of Cutaneous Metastases From Breast Carcinoma. Journal of Experimental and Clinical Medicine, Volume: 27 Issue: 1. https://ajindex.com/articles/1423934
Cox, S.E., 1994. A spectrum of inflammatory metastasis to skin via lymphatics: Tree cases of carcinoma erysipeloides. J. Am. Acad. Dermatol. 30, 304-313
Gutierrez, J.W., Rodriguez M.A., 2007. Carcinoma erysipeloides associated with breast carcinoma. Int. J. Dermatol. 46, 613-614
Hamamoto, Y., Nagai, K., Ichimiya, M., 2001. Regressive effect of intralesional injection of a moderate dose of recombinant interleukn-2 on carcinoma erysipeloides from gastric carcinoma. Clin. Exper. Dermatol. 26, 42-44
Homler, H.J., Goetz, C.S., Weisenburger, D.D., 1986. Lymphatic cutaneous metastases from lung cancer mimicking cellulitis: Carcinoma erysipeloides. West. J. Med.144, 610-612
Lever, L.R., 1991. Carcinoma erysipeloides. Br. J. Dermatol.124, 279-282
Lookingbill, D.P., 1993. Cutaneous metastases in patients with metastatic carcinoma: A retrospective study of 4020 patients. J. Am. Acad. Dermatol. 29, 228
Nambi, R., Tharakaram, S., 1999. Carcinoma erysipeloides as a presenting feature of breast carcinoma. Int. J. Dermatol. 38, 367-376